BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Pfizer Inc. Announces Pricing Terms of Private Exchange Offer for Its 6.500 Per Cent. Notes Due 2038 Open to Certain Investors and Related Tender Offer Open to All Investors

  The Exchange Offer will expire at 5:00 p.m. (New York time) today, December 14, 2017

  December 14, 2017

   · 

  18 min read
• Business

  Cinfa Biotech Begins U.S. Partnering and Prepares U.S. Development for B12019, a Proposed Biosimilar to Neulasta (Pegfilgrastim)

  Cinfa Biotech S.L. today announced the start of US partnering and the preparation of US development for its drug candidate B12019, a biosimilar of Neulasta to treat chemotherapy-induced neutropenia.

  December 14, 2017

   · 

  2 min read
• Reverdia’s Biosuccinium S Granted Halal and Kosher Certifications

  Reverdia has been awarded Halal and Kosher certifications for its Biosuccinium S grade of bio-succinic acid.

  December 14, 2017

   · 

  1 min read
• Business

  Rockwell Medical Signs Exclusive License Agreement With Comercializadora BioRenal SpA to Commercialize Triferic in Chile

  Rockwell’s Triferic is the only FDA approved therapy to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia.

  December 14, 2017

   · 

  6 min read
• Business

  Counsyl Appoints Pamela Sedmak to Board of Directors

  Counsyl today announced the appointment of Pamela Sedmak, former president and chief executive officer of Aetna Medicaid/Dual Eligibles and current senior advisor at McKinsey & Company, to the company’s board of directors.

  December 14, 2017

   · 

  3 min read
• Drug Development

  Cellectar Files IND for Phase I Trial of CLR 131 in Pediatric Cancers

  The study will be initiated with the pediatric oncologists and Nuclear Medicine/Radiology Group at The University of Wisconsin Carbone Cancer Center.

  December 14, 2017

   · 

  6 min read
• Drug Development

  FDA Grants Orphan Drug Designation to Zytoprotec’s Novel Dialysis Fluid

  The orphan designation will provide Zytoprotec with several development incentives including market exclusivity for up to seven years upon FDA approval.

  December 14, 2017

   · 

  1 min read
• Business

  Dimerix and Proteomics Partner to Improve Treatment of Chronic Kidney Disease

  Proteomics International and Dimerix will evaluate the performance of PromarkerD alongside DMX-200 in early phase clinical trials for chronic kidney disease.

  December 14, 2017

   · 

  2 min read
• BioMidwest

  DiaMedica Therapeutics Announces Non-Brokered Private Placement

  The Offering is being offered on a non-brokered private placement basis to accredited investors.

  December 14, 2017

   · 

  4 min read
• Drug Development

  IU Researchers Identify Way to Block Malaria-Causing Parasites’ Ability to Shield Themselves Against Popular Drug Treatment

  Indiana University School of Medicine researchers have identified a way to block the ability of parasites that cause malaria to shield themselves against drug treatments in infected mice-a finding that could lead to the development of new approaches to combat this deadly disease in humans.

  December 14, 2017

   · 

  2 min read